國立科技(300716.SZ):證券簡稱擬變更為“泉為科技”
格隆匯2月8日丨國立科技(300716.SZ)公佈,因公司控股股東及實際控制人已發生變更,為從公司名稱上明確上市公司目前的控股關係,塑立公司品牌,公司擬變更公司名稱及證券簡稱,證券代碼不變。
變更前,公司中文名稱為“廣東國立科技股份有限公司”,英文名稱為“Guangdong Guoli Sci and Tech Co., Ltd.”,證券簡稱為“國立科技”;
擬變更後,公司中文名稱為“廣東泉為科技股份有限公司”,英文名稱為“Guangdong Quanwei Technology Co., Ltd.”,證券簡稱為“泉為科技”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.